Matthew Gline
Amministratore Delegato presso ROIVANT SCIENCES LTD.
Patrimonio netto: 12 M $ in data 30/04/2024
Posizioni attive di Matthew Gline
Società | Posizione | Inizio | Fine |
---|---|---|---|
ROIVANT SCIENCES LTD. | Direttore/Membro del Consiglio | - | - |
Amministratore Delegato | 01/01/2021 | - | |
Direttore Finanziario/CFO | 01/09/2017 | 01/01/2021 | |
Sumitovant Biopharma, Inc.
Sumitovant Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Sumitovant Biopharma, Inc. provides biotechnology services. It offers oncology, gene therapy, rare, pulmonary, urological disease, digital innovation and novel platforms. The company is headquartered in New York, NY. | Direttore/Membro del Consiglio | - | - |
Roivant Sciences GmbH
Roivant Sciences GmbH Pharmaceuticals: MajorHealth Technology Roivant Sciences GmbH engages in the development and marketing of biopharmaceutical products. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in Basel, Switzerland. | Amministratore Delegato | 01/01/2021 | - |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Amministratore Delegato | 01/01/2021 | - |
Direttore Finanziario/CFO | 01/03/2016 | 01/01/2021 | |
Roivant Social Ventures, Inc. | Direttore/Membro del Consiglio | 01/03/2016 | - |
Segretario Aziendale | 01/03/2016 | - |
Storia della carriera di Matthew Gline
Precedenti posizioni note di Matthew Gline
Società | Posizione | Inizio | Fine |
---|---|---|---|
ROIVANT SCIENCES LTD. | Direttore/Membro del Consiglio | - | - |
Amministratore Delegato | - | - | |
UROVANT SCIENCES LTD. | Direttore/Membro del Consiglio | 01/07/2018 | - |
Formazione di Matthew Gline
Harvard College | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 6 |
Bermuda | 2 |
Svizzera | 2 |
Posizioni
Director/Board Member | 5 |
Chief Executive Officer | 4 |
Director of Finance/CFO | 2 |
Settori
Health Technology | 6 |
Finance | 2 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
ROIVANT SCIENCES LTD. | Health Technology |
Aziende private | 6 |
---|---|
Urovant Sciences Ltd.
Urovant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Urovant Sciences Ltd. is a clinical-stage biopharmaceutical company, which through its subsidiaries, engages in the development and commercialization of therapies for urologic conditions. Its pipeline includes Vibegron (RVT-901) and URO-902. The company was founded on January 27, 2016 and is headquartered in London, the United Kingdom. | Health Technology |
Sumitovant Biopharma, Inc.
Sumitovant Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Sumitovant Biopharma, Inc. provides biotechnology services. It offers oncology, gene therapy, rare, pulmonary, urological disease, digital innovation and novel platforms. The company is headquartered in New York, NY. | Health Technology |
Roivant Sciences GmbH
Roivant Sciences GmbH Pharmaceuticals: MajorHealth Technology Roivant Sciences GmbH engages in the development and marketing of biopharmaceutical products. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in Basel, Switzerland. | Health Technology |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Health Technology |
Montes Archimedes Acquisition Corp.
Montes Archimedes Acquisition Corp. Financial ConglomeratesFinance Montes Archimedes Acquisition Corp operates as a blank check company. It is formed for the business purpose to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded James C. Momtazee and Maria C. Walker on July 6, 2020 and is headquartered in Menlo Park, CA. | Finance |
Roivant Social Ventures, Inc. |
- Borsa valori
- Insiders
- Matthew Gline
- Esperienza